Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily-Reference-Cited by-同舟云学术

Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily

Published:2022-04 Issue: Volume:Volume 14 Page:1341-1352
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Stella Stefania^ORCID,Vitale Silvia Rita,Martorana Federica,Massimino Michele,Pavone Giuliana,Lanzafame Katia,Bianca Sebastiano,Barone Chiara,Gorgone Cristina,Fichera Marco,Manzella Livia

Publisher

Informa UK Limited

Subject

Oncology

Reference54 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

3. US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status

4. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

5. Breast cancer prognostic classification in the molecular era: the role of histological grade

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing;World Journal of Oncology;2024-08

2. In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients;Genes;2024-07-18

3. Navigating the Nexus: HIV and Breast Cancer—A Critical Review;International Journal of Molecular Sciences;2024-03-12

4. BRCA mutation status and pathological characterization of breast cancer in Zhoushan Islands, China;Journal of International Medical Research;2024-01

5. A nomogram model combining ultrasound-based radiomics features and clinicopathological factors to identify germline BRCA1/2 mutation in invasive breast cancer patients;Heliyon;2024-01